1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Qatar Pharmaceuticals and Healthcare Report Q3 2016

Qatar Pharmaceuticals and Healthcare Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 84 pages

Includes 3 FREE quarterly updates

BMI View: Rising demand for healthcare, as well as public and private investment in healthcareinfrastructure, will translate to commercial opportunities for pharmaceutical and healthcare operators inQatar over the forecast period. However, we highlight a deceleration in the pace of government investmentin healthcare capital projects as authorities will instead prioritise infrastructure projects related to theFIFA 2022 World Cup. Moreover, Qatar's government will attempt to contain buoyant healthcare coststhrough the promotion of a greater role by private health insurance providers in the health system, asidefrom the recent downward price revision for several drug segments in an attempt to harmonise drug pricesacross the Gulf Cooperation Council bloc.

Headline Expenditure Projections

- Pharmaceuticals: QAR1.91bn (USD524mn) in 2015 to QAR2.03bn (USD557mn) in 2016; +6.4% inlocal currency and US dollar terms. Forecast broadly in line with last quarter.

- Healthcare: QAR17.55bn (USD4.82bn) in 2015 to QAR18.54bn (USD5.09bn) in 2016; +5.7% in bothlocal currency and US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Qatar Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Qatar 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Qatar 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Qatar 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Qatar 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Qatar 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Qatar 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Qatar 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Qatar 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Qatar 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Qatar 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Qatar 2014-2020) 29
Industry Risk/Reward Index 30
Middle East and Africa Risk/Reward Index - Q3 2016 30
Qatar Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 44
Pricing And Reimbursement Regime 44
Market Overview 48
Healthcare Sector 49
Table: Healthcare Resources (Qatar 2010-2015) 53
Table: Healthcare Personnel (Qatar 2010-2015) 53
Table: Healthcare Activity (Qatar 2010-2015) 54
Research and Development 58
Clinical Trials 60
Epidemiology 60
Competitive Landscape 63
Research-Based Industry 63
Table: Multinational Company Activity 65
Pharmaceutical Distribution and Retail Sector 66
Company Profile 67
Ebn Sina Medical 67
Medicare Group 69
Qatar Pharma 71
Demographic Forecast 73
Table: Population Headline Indicators (Qatar 1990-2025) 74
Table: Key Population Ratios (Qatar 1990-2025) 74
Table: Urban/Rural Population and Life Expectancy (Qatar 1990-2025) 75
Table: Population By Age Group (Qatar 1990-2025) 75
Table: Population By Age Group % (Qatar 1990-2025) 76
Glossary 78
Methodology 80
Pharmaceutical Expenditure Forecast Model 80
Healthcare Expenditure Forecast Model 80
Notes On Methodology 81
Risk/Reward Index Methodology 82
Index Overview 83
Table: Pharmaceutical Risk/Reward Index Indicators 83
Indicator Weightings 84

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.